Researchers discussed external devices that would allow individuals to monitor clinical and subclinical seizure activity in their home environment
Lauren Whetzel Siburkis
Advertisement
Articles by Lauren Whetzel Siburkis
Results of an MRI study and a 50-year follow-up study shed light on the effects of epilepsy on the brain’s aging process.
Important bioequivalence issues regarding anti-epileptic drugs were highlighted at the FDA Town Hall meeting held during AES 2015.
During pre-surgery planning, decisions regarding which electrode(s) to utilize must be made on a case-by-case basis.
Experts from around the globe met to discuss the neuropsychological aspects of frontal lobe epilepsy.
How can the medical community advance research and tackle the difficult issue of sudden unexplained death in epilepsy (SUDEP)?
Advertisement
Latest Updated Articles
Public Health’s Role in Reducing SUDEP RiskDecember 6th 2015
- A Multicultural Assessment of Frontal Lobe Epilepsy
December 7th 2015
- Seizure Analysis: Stereo EEG vs. Subdural Electrodes
December 8th 2015
Generic vs Brand-Name Anti-Epileptic DrugsDecember 9th 2015
- Consequences of Epilepsy on the Aging Brain
December 10th 2015
- Future of Personal Monitoring Devices for Epilepsy
December 12th 2015
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Roche Unveils PrevenTRON, a Phase 3 Prevention Trial of Trontinemab in Cognitively Unimpaired Individuals at High Risk of Alzheimer Decline
2
Alzheimer's Association Launches PROTECT-Cog Combination Prevention Trial
3
Sanofi's Oral TREM2 Agonist SAR448851 Advances to Phase 2 TREMHANCE Trial in Early Alzheimer Disease
4
FDA Accepts BLA for Z-Rostudirsen in DMD, Sets January PDUFA Date
5